The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause-Reference-Cited by-同舟云学术

The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause

Published:2020-02 Issue: Volume:112 Page:104512
ISSN:0306-4530
Container-title:Psychoneuroendocrinology
language:en
Short-container-title:Psychoneuroendocrinology

Author:

Kimball Allison,Dichtel Laura E.,Nyer Maren B.,Mischoulon David,Fisher Lauren B.,Cusin Cristina,Dording Christina M.,Trinh Nhi-Ha,Yeung Albert,Haines Melanie S.,Sung Joshua C.,Pinna Graziano,Rasmusson Ann M.,Carpenter Linda L.,Fava Maurizio,Klibanski Anne,Miller Karen Klahr

Funder

National Institutes of Health

Harvard Catalyst/The Harvard Clinical and Translational Science Center

National Center for Research Resources

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Reference45 articles.

1. Progesterone effects during sequential hormone replacement therapy;Andreen;Eur. J. Endocrinol.,2003

2. Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states;Bixo;Brain Res.,1997

3. Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naive patients with schizophrenia;Cai;Psychoneuroendocrinology,2018